QA: Paratek Pharmaceuticals Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2020_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 243,354,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 1,227,000
3 remainder_Assets 5,669,000
4 LiabilitiesCurrent 24,200,000
5 LiabilitiesNoncurrent 266,526,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 3,484,000
8 SellingGeneralAndAdministrativeExpense 153,142,536
9 ResearchAndDevelopmentExpense 35,173,388
10 remainder_Expenses 27,049,206
11 remainder_Revenues 16,585,337
12 remainder_NetIncome 3,497,188
13 remainder_ComprehensiveNetIncome 239,514
  yvar yval
0 Assets 251,079,000
1 Liabilities 290,726,000
2 Expenses 218,849,130
3 Revenues 16,585,337
4 StockholdersEquity -39,647,000
5 NetIncome -198,766,605
6 ComprehensiveNetIncome -198,646,848
7 BaseVar 390,488,084
8 EconomicCapitalRatiobeforeLimitedLiability -1.05
9 EconomicCapitalRatio 1.29

Edgar->Model Mapping

Feature Distribution

Change over Time